Pathogenic role of acrolein in alcoholic liver disease. by Chen, Wei-Yang (Jeremy)
University of Louisville
ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
12-2014
Pathogenic role of acrolein in alcoholic liver disease.
Wei-Yang ( Jeremy) Chen
University of Louisville
Follow this and additional works at: https://ir.library.louisville.edu/etd
Part of the Digestive System Diseases Commons
This Master's Thesis is brought to you for free and open access by ThinkIR: The University of Louisville's Institutional Repository. It has been accepted
for inclusion in Electronic Theses and Dissertations by an authorized administrator of ThinkIR: The University of Louisville's Institutional Repository.
This title appears here courtesy of the author, who has retained all other copyrights. For more information, please contact thinkir@louisville.edu.
Recommended Citation










Wei-Yang (Jeremy) Chen 
B.S. in Chemistry, Tamkang University, Taipei, 2003 





Submitted to the Faculty of the  
School of Medicine of the University of Louisville  
In Partial Fulfillment of the Requirements  




Masters of Science 
 
 
Department of Pharmacology and Toxicology 















Wei-Yang (Jeremy) Chen 
B.S. in Chemistry, Tamkang University, Taipei, 2003 
M.S. in Biochemistry, University of North Carolina-Greensboro, 2009 
 
A Thesis Approved on 
 
 




By the following Thesis Committee 
 
________________________________ 
Craig McClain, M.D. 
________________________________ 
Swati Joshi-Barve, Ph.D 
________________________________ 
David Hein, Ph.D. 
_____________________________ 
Sanjay Srivastava, Ph.D. 
_____________________________  






I would like to thank my mentors Dr. Craig McClain and Dr. Swati Joshi-Barve, I 
could not come this far without their support, guidance and encouragement. I 
would also like to thank my graduate committee members: Dr. Shirish Barve, Dr. 
David Hein, and Dr. Sanjay Srivastava for their guidance, expertise and precious 
advice in my academic career at the University of Louisville. I would like to 
express my gratitude to all the members of the McClain/Barve lab for their help 
and support. And finally, I would like to thank my parents and sister for their 
continuous support and sacrifices in order for me to have an excellent education 

















PATHOGENIC ROLE OF ACROLEIN IN ALCOHOLIC LIVER DISEASE  
Wei-Yang (Jeremy) Chen 
November 20, 2014 
Alcohol is the most socially accepted addictive drug, and it can cause alcoholic 
liver disease (ALD), which is a major cause of morbidity and mortality in the 
United States and worldwide. Animal and human studies demonstrate that 
chronic alcohol consumption causes a pro-oxidant environment in the liver and 
increases hepatic lipid peroxidation and the accumulation of by-products such as 
acrolein and 4-hydroxynonenal. Acrolein is the most reactive and toxic aldehyde 
generated through lipid peroxidation. Also, acrolein is a major component of 
cigarette smoke, and there is increasing evidence that smoking negatively 
impacts the incidence, severity, and clinical course of chronic liver disease. 
Acrolein is known to form protein adducts, and can trigger endoplasmic reticulum 
(ER) stress. Notably, alcohol-induced perturbations in the ER have emerged as 
an important etiologic factor in alcoholic liver disease. This study investigated the 
role of acrolein as a mediator of hepatic ER stress and injury during alcohol 




JNK (	the mitogen activated protein kinase c-jun N-terminal kinase) , ER stress, 
and apoptotic cell death was examined in vitro in alcohol-exposed rat hepatic 
cells (H4IIEC), and in vivo in a mouse model of alcohol consumption. Exposure 
to alcohol led to substantial accumulation of acrolein adducts both in vitro and in 
vivo. This was accompanied by phospho-activation of JNK and upregulation of 
ER stress transcription factors ATF3 and ATF4, and the pro-apoptotic protein, 
GADD153/CHOP. This study demonstrates that acrolein is likely to be a major 
culprit in the ER stress and hepatotoxicity associated with alcohol consumption. 
Also, the data show that acrolein removal protects against alcohol-induced ER 
stress and injury, suggesting that acrolein scavengers may have therapeutic 
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 Alcohol liver disease (ALD)  
Alcohol is the most socially accepted addictive drug, and alcohol 
abuse/dependence is known to cause chronic organ disorders [1]. Alcohol abuse 
is the 3rd leading lifestyle-related cause of death in the United States and there 
are approximately 80,000 deaths annually attributed to excessive alcohol use [2, 
3]. Binge and underage drinking are common types of excessive alcohol use and 
both are also linked to a wide range of health and social problems. Excessive 
alcohol use also costs about $185 billion each year in health care and criminal 
justice expenses, as well as lost productivity in the United States.  
Alcohol quickly distributes into the portal circulation and across biological 
membranes to organs throughout the body. Alcohol injuries are observed in 
many organs including brain, gastrointestinal tract, immune system, kidney, lung, 
heart, pancreas, and particularly, the liver. In the liver, alcohol consumption is 
known to cause alcoholic liver disease (ALD) which includes a spectrum of liver 
disorders (Figure 1), ranging from fatty liver (steatosis), steatohepatitis, and 
fibrosis, to cirrhosis, end stage liver disease and hepatocellular carcinoma (HCC) 
[4]. Steatosis is commonly found in approximately 90 percent of individuals who 
consume more than 60 g per day of alcohol or about five drinks per day [5]. 




alcohol consumption. Histology evidence has shown fat accumulation of both 
small (i.e., microvesicular) and large (i.e., macrovesicular) droplets within liver 
cells [6]. Some individuals with steatosis progress to more serious liver disease 
such as alcoholic hepatitis, which is a steatosis accompanied by inflammation, 
neutrophil infiltration, hepatocyte necrosis, and Mallory bodies. Approximately 35 
to 40 percent of alcoholic patients may progress from steatosis to fibrosis and 
eventually cirrhosis followed by end stage liver disease and hepatocellular 
carcinoma (HCC). Currently, there is no FDA approved therapy for any stage of 
ALD; hence, the study of mechanisms and mediators that contribute to ALD is 
critical to understand the development and progression of ALD and to promote 
therapeutic development.  
 





Alcohol metabolism and oxidative stress 
The portal circulation from the intestine passes first through the liver and 
ingested alcohol is primarily metabolized in the liver. The process of ethanol 
metabolism involves at least three distinct enzymatic pathways.  Most of the 
alcohol in the human body is first oxidized in the liver to toxic acetaldehyde, 
catalyzed by the cytosolic alcohol dehydrogenase (ADH), an NAD+-requiring 
enzyme expressed at high concentrations in hepatocytes. ADH oxidizes ethanol 
to acetaldehyde, which enters the mitochondria where it is oxidized to acetate by 
one of several aldehyde dehydrogenases (ALDH). Acetaldehyde is then 
converted by acetaldehyde dehydrogenase (ALDH) to acetic acid [7]. The 
second major pathway for ethanol metabolism is the microsomal ethanol 
oxidizing system (MEOS) which involves the cytochrome P450 enzyme 2E1 
(CYP2E1) and requires NADPH instead of NAD+ as for ADH. The MEOS 
pathway is highly induced in individuals who chronically consume alcohol. 
CYP2E1 also plays an important role in alcohol metabolism; alcohol can be 
oxidized by CYP2E1 to acetaldehyde, with generation of hydrogen peroxide 
which causes oxidative stress in the liver cells. Minor pathways for alcohol 
metabolism involve fatty acid ethyl ester (FAEE) synthase, or catalase in 
peroxisomes.  
Studies have shown that consumption of ethanol disrupts antioxidants function, 
which leads to elevated oxidative stress and increased interactions between free 
radicals and cellular components including lipids, proteins, and DNA, which alter 




production of reactive oxygen species (ROS) and a disturbance of cellular 
antioxidant capacity. These physiological conditions can be adapted by the 
antioxidant systems of the human body. However, when excessive ROS 
production goes over the capacity of physiological adaption to eliminate ROS, it 
could lead to health problems. The superoxide and hydrogen peroxide are the 
most dominant form of ROS and they can cause acetaldehyde accumulation due 
to imbalance of redox state. Aldehyde dehydrogenase (ADH) is responsible for 
the oxidation of ethanol by increasing the reduced form of nicotinamide adenine 
dinucleotide (NADH) which results in decreasing of NAD+/NADH ratio and 
triggers the conversion of cytosolic xanthine dehydrogenase to xanthine oxidase 
which is the enzyme responsible for the production of superoxide radicals. NADH 
is involved in the conversion of ferritin to ferrous (Fe) (II) ions and these ferrous 
ions play important roles in free radical reactions which lead to the generation of 
hydrogen peroxide, hydroxyl radicals, and increased lipid peroxidation [8, 9]. 
Alcohol-induced lipid peroxidation 
Alcohol metabolism in the liver generates free radicals and these free radicals 
can lead to oxidative degradation of cellular polyunsaturated fatty acids (PUFAs), 
a process called lipid peroxidation [10]. Linoleic acid (LA) is the most common 
PUFA found in all foods in the western diet [11]. The consumption of LA has 
dramatically increased from 2% to over 7% in the last decade. Notably, studies 
by our group and others have shown that consumption of alcohol along with a 
diet rich in PUFA (particularly, LA) gives rise to worse alcohol-induced liver injury, 




arachidonic acid converted to proinflammatory eicosanoids; these are thought to 
be involved in several chronic diseases including cancer and cardiovascular 
disease [13]. Linoleic acid enriched diet is known to elevate lipid peroxidation [14] 
which can generate higher acrolein in the body [15]. 
Free radicals produced by alcohol metabolism can damage the cells membrane 
by stealing electrons from the lipids in cell membranes in the process of free 
radical chain reaction. Alcohol-induced lipid peroxidation is well documented in 
animal models, as well as in patients with ALD [16]. The products of lipid 
peroxidation including malondialdehyde (MDA), 4-hydroxynonenal (4-HNE) and 
acrolein are detected in animal blood or tissues and in the humans consuming 
alcohol; these highly reactive aldehydes are likely to play a critical role in the 
pathology of ALD (Figure 2). Due to their chemical nature, these electrophiles 
can react with cellular protein nucleophiles and form aldehyde-modified protein 
adducts which generate a pro-oxidative environment in the liver, further 
promoting lipid peroxidation. These aldehyde protein adducts can serve as 






Figure 2: Proposed formation of acrolein from arachidonic acid (PUFA) 
[17]. 
 
Acrolein, the reactive aldehyde from lipid peroxidation 
Acrolein, a highly reactive α,β-unsaturated aldehyde with three carbon and a 
double bond structure (Figure 3), is formed endogenously during lipid 
peroxidation [18]. Acrolein is also a biotransformation metabolite formed from 
certain amino acids, allyl compounds and the anticancer drug cyclophosphamide 
[15]. Acrolein has the potential to rapidly deplete cellular glutathione, and 
reduces cellular antioxidant capacity [18]. Therefore acrolein may serve as an 
important oxidative stress biomarker for lipid peroxidation [19]. Acrolein is the 




more reactive than HNE [15]. Due to its highly electrophilic nature, acrolein can 
form adducts with cellular nucleophilic groups in lipids, nucleic acids, and 
proteins; these acrolein adducts can cause cytotoxicity via irreversible adduction 
by disrupting cell signaling and mitochondrial dysfunction of the cells and 
produce oxidative stress. Acrolein is associated with several chronic diseases 
and elevated concentration of acrolein/acrolein-protein adducts are detected in 
the plasma of patients with chronic renal failure, Alzheimer’s disease, 
Parkinson’s disease,  atherosclerosis, and chronic obstructive lung disease [18].  
Notably, acrolein is also an environmental pollutant arising from combustion of 
wood, paper, fossil fuels, and plastics. It is a major component of cigarette smoke 
and up to 600µg of acrolein is generated per cigarette [20]. This is particularly 
relevant for ALD given the high prevalence of individuals that use/abuse both 
alcohol and cigarettes. Additionally, acrolein is produced by overheating fats and 
oils, and is now considered a significant dietary pollutant occurring in charred 
meats and fried foods [18, 20]. Thus, both exogenous and endogenous acrolein 
generation may contribute to the development/progression of liver diseases. 
 






The pathogenic mechanisms of alcohol liver disease 
Some mechanisms postulated to contribute to ALD include inflammation, 
mitochondria dysfunction, ER stress, hepatocyte apoptosis and intestinal barrier 
dysfunction.  
Mitochondria dysfunction 
Mitochondria are the energy factory of the cells which produce ATP required to 
maintain normal metabolic and repair functions of the cells. Studies have shown 
that alcohol significantly decreases the viability of hepatocytes due to inability to 
maintain sufficient rate of ATP synthesis. The oxidation of alcohol by ALD and 
CYP2E1 and acetaldehyde by ALDH leads to significant increase in the hepatic 
NADH/NAD+ ratio and in the production of ROS. The enzyme activities of NADH 
dehydrogenase, succinate dehydrogenase and ATP synthase are depressed 
when exposed to reactive species, including superoxide, hydrogen peroxide and 
peroxynitrite which result in the inactivation of mitochondria proteins and further 
decreases the function of mitochondria in the cells [16, 21]. Disruption of 
mitochondrial function can trigger signaling cascades involving the release of 
pro-apoptotic protein from mitochondria, and activation of initiator and effector 














Inflammation is an early indicator of more serious liver disease and several 
inflammatory response pathways are linked to alcohol liver disease such as 
NFκB, JNK, ROS, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). TNF-
α is a cytokine which responsible for the programmed cell death and apoptosis of 
hepatocytes in alcohol-induced liver injury. TNF-α promotes a series of 
inflammation responses in the cells and leads to the production of inflammatory 
cytokines such as IL-1β, IL-6, and IL-8 [22]. Persistent cytokine secretion causes 
chronic inflammation in the cells which leads to hepatitis, fibrosis, and cirrhosis 
[23].  
Endoplasmic Reticulum (ER) stress and unfolded protein response (UPR)  
The endoplasmic reticulum (ER) is an eukaryotic cell organelle composed of low 
concentrations of cholesterol and sphingolipids [24]. The ER plays a crucial role 
in cell homeostasis and survival, and is responsible for synthesis, folding, 
assembly, and trafficking of proteins, lipid biosynthesis, and regulation of 
intracellular calcium and redox homeostasis [25]. The molecular 
chaperones/folding proteins in the ER (e.g., Grp78/BiP, Grp94, protein disulfide 
isomerase (PDI), calnexin, and calreticulin) ensure that only properly folded 
proteins reach their destinations; inappropriately folded proteins are retained in 
the ER lumen for refolding or endoplasmic reticulum–associated degradation 
(ERAD) [25]. Certain stimuli (such as altered redox status, oxidative stress, 
unbalanced calcium, hypoxia, or energy deprivation) can disturb ER function and 




stress and the unfolded protein response (UPR). To restore ER homeostasis, the 
UPR adaptive mechanism upregulates the folding capacity of the ER through 
induction of chaperones and foldases, and downregulates the biosynthetic load 
through inhibition of protein synthesis. UPR adaptive responses can re-establish 
homeostasis and reduce ER stress via (i) increased folding capacity through 
upregulation of chaperones, and (ii) decreased protein burden through inhibition 
of protein synthesis and degradation of misfolded proteins [25].  
ER stress/UPR signaling pathways involves three major ER resident 
transmembrane sensor proteins, inositol requiring protein 1 (IRE1), ds-RNA-
activated protein kinase (PKR) like ER kinase (PERK), and activating 
transcription factor 6 (ATF6), which are activated from their inhibitory binding with 
chaperone GRP78/BiP. The first sensor IRE1, a type I transmembrane protein 
with both a serine/threonine kinase domain and an endoribonuclease (RNase) 
activities, is activated by transautophosphorylation. IRE1 transcriptionally form 
active spliced XBP1 (sXBP1) which activates UPR target genes and ERAD 
pathway genes. IRE1 also activates the stress-signaling kinase, JNK, and the 
transcription factor NFκB; both of which can lead to proinflammatory cytokine 
production. The second sensor PERK, a type I transmembrane protein with a 
cytosolic serine/threonine kinase domain, phosphorylates the eukaryotic initiation 
factor 2α-subunit (eIF2α), leading to inhibition of translation and reduction of the 
protein load during ER stress. Also, p-eIF2α triggers activating transcription 
factor 4 (ATF4), which regulates ER chaperone genes, ERAD pathway genes, 




homologous protein (CHOP, GADD153). The third sensor ATF 6, a type II ER 
transmembrane protein with a CREB/ATF bZIP transcription factor domain at the 
amino terminus, is activated by cleavage in the golgi and can translocate to the 
nucleus to activate chaperone gene expression [26, 27]. Additionally, ATF6 also 
leads to upregulation of CHOP, and affects SREBP activity and consequently, 
lipogenesis.  
ER stress induces apoptosis  
In order to counter ER stress in the cells, the UPR adaptive signaling pathway is 
triggered. However, excessive or prolonged ER stress can overcome the 
adaptive pathways, and cause apoptosis and necrotic cell death. The apoptosis 
pathway is triggered to protect the liver if the PERK, ATF6, and IRE1 adaptive 
pathways fail to mitigate ER stress [28]. Several mechanisms are involved in ER 
stress-induced apoptosis such as the transcription factor C/EBP homologous 
protein (CHOP), JNK, Bcl-2 family proteins, calcium and redox homeostasis, and 
caspase activation [15]. 
ER stress triggers JNK pathway via phosphorylation of IRE-1 with the adaptor 
protein TRAF2 (tumor necrosis factor receptor (TNFR)-associated factor-2) which 
phosphorylates and activates JNK [29]. Phosphorylated JNK activates 
proapoptotic Bim and inactivates antiapoptotic Bcl-2 proteins, and triggers 
release of cytochrome C through the mitochondrial death pathway. Calcium 
homeostasis is associated with apoptosis; excess calcium release from the ER 




effectors release from mitochondria into the cytosol. Bcl-2 has the ability to 
reduce overflow of free calcium rest in the ER and prevent cell apoptosis.  
The transcription factor CHOP/GADD153 is the best-known proapoptotic 
pathway associated with ER stress. CHOP is a bZIP-containing transcription 
factor that is a common point of convergence for all three arms of the UPR, with 
binding sites for ATF6, ATF4 and XBP1s present within its promoter. CHOP is 
primarily considered a pro-apoptotic transcription factor that mediates ER stress 
induced cell death through the regulation of Bcl-2 family members. Also, CHOP 
transcriptionally induces GADD34 and dephosphorylates p-eIF2α to enable 
protein synthesis, concomitantly generating ROS and leading to oxidative stress 
and inflammation [15]. The activation of ER stress, and consequent inflammation 
and apoptosis may be a significant contributor to many forms of liver injury, 
including ALD.  
ER stress has been reported to contribute to alcohol-induced liver injury and the 
progression of alcohol live disease in both animal and cell models [30-33]. 
Upregulation of ER stress related genes such as Grp78, Grp94, and CHOP has 
been observed in acute and chronic alcohol feeding animal models and in patient 
biopsies [34, 35]. Some factors that are thought to contribute to alcohol-induced 
ER stress include acetaldehyde, oxidative stress, disrupted calcium homeostasis, 









We hypothesize that the lipid metabolite acrolein is a major pathogenic 
contributor to ALD, based on the knowledge that alcohol metabolism via ADH 
and CYP2E1 increases lipid peroxidation  leading to the generation/accumulation 
of lipid-derived acrolein, which forms protein adducts and triggers ER stress, 
ultimately leading to cell death and liver injury. 
The study of cellular mechanisms and pathogenic mediators that 
contribute to ALD is critical to understand the development/progression of ALD 
and to promote therapeutic development. In this study, we investigated the 
pathological contribution of acrolein in a murine model of alcohol-induced liver 
disease, and we demonstrate that alcohol-induced generation of acrolein in the 













MATERIALS AND METHODS 
Animal studies  
Male C57BL/6J mice (10 weeks of age) were obtained from Jackson laboratories 
(Bar Harbor, ME). They were maintained at 24°C with a 12h:12h light/dark cycle 
and had free access to normal chow diet and tap water for 5 days before the start 
of the experiment. The mice were fed (ad libitum) a Lieber-DeCarli liquid diet 
(Bio-Serv Inc., Frenchtown, NJ) containing 5% ethanol (w/v or 35% of calories) or 
maltose dextrin as control for 10 days, followed by a single oral gavage of 
ethanol (5g/kg body weight) on day 11. At the end of the experiment, the mice 
were anesthetized with Avertin. Plasma and tissue samples were collected for 
assays.  Part of the liver from the left lobe was harvested and fixed in 10% 
neutral-buffered formalin, while the remaining liver tissue was snap frozen in 
liquid N2 and stored at −80°C. All mice were treated according to the protocols 
reviewed and approved by the Institutional Animal Care and Use Committee of 
the University of Louisville. 
Reagents 
General chemicals, N-acetyl cysteine (NAC), acrolein, and β-actin antibody were 
purchased from Sigma Aldrich (St. Louis, MO).  All other antibodies were 
purchased from Cell Signaling (Beverly, MA).  Cell culture supplies were 







H4IIEC, a rat hepatoma cell line obtained from American Type Culture Collection 
(Rockville, MD) was used according to company instructions.  All treatments 
were performed on sub-confluent monolayers of cells.  Cells were plated at the 
following densities: (i) 20,000 cells per well for 96-well plates; (ii) 0.25x106 cells 
per well for 24-well plates; (iii) 0.5x106 cells per well for 6-well plates; (iv) 2.5x106 
cells per 100mm plates. Cells were cultured in the DMEM media (10% horse 
serum, 5% .Cells were counted using a hemocytometer.  
Isolation of RNA and RT-PCR 
The messenger RNA (mRNA) levels of ER stress genes were analyzed by real 
time polymerase chain reaction (RT-PCR). 300ng of total RNA, isolated using 
Trizol (Invitrogen, Carlsbad, CA), was used in reverse transcription reactions as 
described by the manufacturer. The resulting complementary DNA was then 
subjected to PCR using specific primer pairs (Table 1), with 18s and TATA-
binding protein as internal controls. SYBR Green I dye was used for Real Time 



















mGRP78_R1 AGGCCACATACGACGGCGTG  
mGRP94_F1 AAAGGACTTGCGACTCGCCGG 
mGRP94_R1 TCTGACGAACCCGAAGGTCAGC 

















Table 1: Primers for quantitative Real Time-PCR. 
MTT assay 
Cell viability was assessed by the 3-(4,5-dimethythiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. After treatments, cells were washed 
twice with PBS; then cell culture medium was replaced with medium containing 1 




and 50% N,N-dimethyformamide (DMF), and incubated at 37°C overnight. The 
OD values were read at 570 nm. 
Western blot analysis 
Western Blot Analysis: Cells were lysed in lysis buffer (50 mM Tris•HCl, pH 7.4, 
150 mM NaCl, 2 mM EDTA, 4 mM Na3VO4, 40 mM NaF, 1% Triton X-100, 1 mM 
PMSF, 1% protease inhibitor cocktail) and centrifuged at 14,000 g for 10 min. 
The supernatants were collected and 26μg of equivalent protein in total cell 
lysates was resolved by SDS-polyacrylamide gel electrophoresis and transferred 
onto a polyvinylidene difluoride membrane ((Bio-Rad, Hercules, CA). Membranes 
were blocked for 1 h in blocking buffer (5% nonfat dry milk in 0.1%TBST (10 mM 
Tris-HCl, pH 8.0, 150 mM NaCl, and 0.1% Tween 20)) and incubated overnight 
at 4°C with the primary antibodies diluted in blocking buffer.  After washing with 
0.1%TBST, the membranes were incubated with appropriate secondary 
antibodies for 1 h at room temperature. Proteins were visualized using an 
enhanced chemiluminescence system (ECL, GE Healthcare, Piscataway, NJ) 
and quantified by densitometry analysis using UNSCANIT (Silk Scientific, Inc, 
Orem, UT).  The density ratio of each band compared to its corresponding β-
actin band was determined. The density ratio was normalized to the untreated 
value which was set to 1. 
Liver histology:  
Liver sections were fixed in 10% buffered formalin for 24 hours and embedded in 
paraffin. Tissue sections were deparaffinized, stained with hematoxylin–eosin 




ALT & AST assay 
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity 
was measured as a marker of liver injury using commercially available reagents 
from Thermo Fisher Scientific Inc. (Middletown, VA). 
Oil Red O staining 
Frozen liver sections were washed in phosphate buffered saline twice for 5 
minutes. Oil-Red-O and 85% propylene glycol were added with agitation for 15 
minutes, followed by washing in tap water. 
Detection of apoptosis and acrolein adducts 
TUNEL staining for apoptosis was performed using ApopTag® Peroxidase In 
Situ Apoptosis Detection Kit (EMD Millipore Corporation, Billerica, MA). Acrolein 
adducts were detected using an antibody specific for FDP-Lysine acrolein 
adducts obtained from Cell Sciences. (Canton, MA). Quantitation was done and 
calculated by MetaMorph microscope. Ten pictures from each liver were used for 
analyses. 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism version 5.01 for 
Windows (GraphPad Software, Inc., La Jolla, CA). One-way analysis of variance 
(ANOVA) followed by Tukey’s post hoc test was used to evaluate significant 
differences between the compared groups. A p-value of <0.05 was considered 








In this study, we have examined the contribution of the lipid-derived aldehyde, 
acrolein, to alcohol-induced liver injury in a “chronic+binge” murine model of ALD. 
This model reflects a common drinking pattern in humans, particularly in patients 
with ALD who are often chronic and binge drinkers. Moreover, the model has the 
advantage of shorter duration with increased liver inflammation and injury as 
compared to other alcohol feeding models [36, 37].  Figure 5 is a schematic 
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Alcohol consumption results in the accumulation of acrolein adducts in the 
liver 
Alcohol consumption is known to upregulate CYP2E1 and increase oxidative 
stress and LPO, and hence is expected to generate higher levels of the lipid-
derived aldehyde, acrolein. Free acrolein is extremely labile and reactive, and 
difficult to quantify; moreover, it is known to react with amino acid side chains, 
particularly lysine and cysteine, and can form adducts with cellular proteins. 
Accordingly, we examined (i) CYP2E1 gene expression and protein levels, and (ii) 
the levels of acrolein-protein adducts in the livers of control versus alcohol-fed 
mice. Alcohol feeding led to a robust increase in CYP2E1 protein levels (Figure 
6A), but interestingly CYP2E1 mRNA was down-regulated in the alcohol-fed mice. 
Consistent with CYP2E1protein upregulation, a corresponding increase was 
observed in the levels of acrolein-protein adducts in the liver (Figure 6B). Some 
liver sections in the alcohol group had slightly higher accumulation of alcohol-
induced acrolein adducts around the central veins, however, there was no zone-
specific accumulation, and there was no particular increase in acrolein adducts at 
the sinusoids. In the majority of liver sections, elevated acrolein staining was 
seen in both cytoplasm and nuclei of hepatocytes. The acrolein adduct 
accumulation was quantified and there was a statistically significant difference in 
the adduct levels between control and alcohol-fed livers. Consistent with 
increased acrolein adducts, alcohol exposed mice also developed microvesicular 


















Figure 6A. Alcohol consumption decreases mRNA and increases CYP2E1 
protein levels in mouse livers.  
Top: CYP2E1 mRNA by real time-PCR. Data are presented as the mean ± SD. 
Statistical analysis was done by student’s t-test. *p,0.05, ***p<0.001compared to 
control (n=5). Bottom: CYP2E1 protein by Western blot analysis of total lysates. 
Blots were reprobed with antibody to β-actin to ensure equivalent loading. 
Densitometry analysis was performed using Imagelab software. Density ratio was 
calculated using β-actin as control. Numbers represent the mean of density ratio 







Figure 6B. Alcohol consumption leads to accumulation of acrolein adducts 
in mouse livers.  
Top: Immunostaining for Acrolein FDP-lysine adducts in liver of control (C) and 
alcohol-fed (E) mice from 10+1 chronic alcohol binge model. 5μM liver sections 
were stained with antibodies for acrolein FDP-lysine adducts. Brown color 





































Bottom: Quantification of acrolein adducts by percentage positive microscope 
fields was calculated by MetaMorph microscopy in control (C) and alcohol-fed (E) 
mice.	Data are presented as the mean ± SD. Statistical analysis was done by 







Figure 6C. Alcohol consumption results in hepatic steatosis in mouse 
livers.  
Liver were stained with Hematoxylin and Eosin staining (H&E, ×200 final 
magnification). Alcohol exposure resulted in microvesicular and macrovesicular 
fat accumulation. Liver sections from mice fed control diet (C) or alcohol (E). 






Figure 6D. Alcohol consumption results in hepatic steatosis in mouse 
livers.  
Liver sections from mice fed control diet (C) or alcohol (E) were stained with Oil-
Red-O (×20 final magnification). Alcohol exposure resulted in microvesicular and 





Alcohol-induced hepatic accumulation of acrolein adducted proteins 
causes ER stress 
The alcohol-induced accumulation of acrolein adducted proteins in the liver is a 
likely burden on the ER protein folding machinery, which if overwhelmed can 
result in the induction of ER stress and activation of UPR. To evaluate the 
consequence of alcohol-induced acrolein adduct accumulation, we therefore 
examined hepatic ER stress following alcohol feeding. Indeed, alcohol feeding 
and resultant accumulation of acrolein adducts led to ER stress and extensive 
upregulation of the prototypical ER stress markers, activating transcription factors 
ATF3 and ATF4, at the mRNA (Figure 7A). In agreement with gene expression, 
western blot analysis also demonstrated increased protein levels in the livers of 
alcohol-fed animals (Figure 7B). The increase in ATF3 and ATF4 could be 
attributed to phospho-activation of the upstream signaling proteins, PKR-like 
endoplasmic reticulum kinase (PERK) and eukaryotic translation initiation factor 
2A, (eIF2α) (Figure 7B). The effect of alcohol consumption was also examined on 
gene expression of ER chaperone proteins GRP-78 and GRP94, which are 
upregulated as part of the adaptation responses to ER stress. Alcohol feeding 
increased the mRNAs of both GRP78 and GRP94 to a small but statistically 
significant extent (Figure 7A); however, at the protein level, only GRP78 was 





Figure 7A. ER stress gene expression is up-regulated in mouse livers. 
mRNA expression was examined by real-time PCR using primers specific for 
ATF3, ATF4, GADD/CHOP, GRP78, and GRP94 genes. Data are presented as 
the mean ± SD (n=6). Statistical analysis was performed using GraphPad Prism 









Figure 7B. Alcohol consumption induces ER stress in mouse livers. 
Western blot analysis of ATF3, ATF4, GADD/CHOP, GRP78, GRP94, and ATF6 
was performed using total cell lysates. Blots were reprobed with antibody to β-
actin to ensure equivalent loading. Statistical analysis was performed using 
GraphPad Prism Software using one-way ANOVA followed by Bonferroni 
posttest. Densitometry analysis was performed using Imagelab software. Density 
ratio was calculated using β-actin as control. Numbers represent the mean of 











Alcohol-induced hepatic acrolein build-up and consequent ER stress lead 
to apoptotic signaling, hepatocyte death and liver injury 
ER stress-induced apoptosis is thought to occur via various apoptotic pathways. 
The first is activation by phosphorylation of the stress kinase JNK (cJUN NH2-
terminal kinase), which is primarily involved in proinflammatory signaling and 
gene expression, but is also linked to hepatocyte apoptosis. Another arm of ER 
stress-associated apoptosis is postulated to involve activation of caspase-12 
(caspase-4 in humans), a phylogenetic family member of the inflammatory 
caspases which is proteolytically activated during ER stress-induced cell death 
[38], rather than other apoptotic pathways. ER stress increases cytosolic calcium 
and activates m-calpain, which cleaves Bcl-XL and proteolytically activates 
caspase12; active caspase12 then activates caspase-9 and caspase-3 [39], 
resulting in apoptosis. The third and possibly the most important pathway of ER-
stress induced apoptosis is upregulation of C/EBP homologous protein (CHOP, 
GADD153), the pro-apoptotic protein primarily responsible for ER stress-induced 
cell death. Accordingly, we examined these apoptotic signals following alcohol 
feeding in mice.  
In hepatocytes, JNK1 (46kDa) and JNK2 (54kDa) are expressed and sustained 
JNK activation has been implicated in several forms of liver injury. In particular, it 
is thought that JNK1 may be responsible for inducing cell death, and JNK2 may 
primarily promote proliferation. In our model system, alcohol caused a significant 
phospho-activation of JNK1 which was undetectable in control mice, while 




level (Figure 8). Also, alcohol feeding led to proteolytic activation of caspase12, 
with a decrease in pro-caspase12 (apparent ~55kDa) and a concurrent increase 
in the cleaved form (38kDa) in mice fed alcohol compared to controls (Figure 8). 
Notably, alcohol consumption also led to the induction of C/EBP homologous 
protein (CHOP, GADD153). CHOP is a pro-apoptotic basic-leucine zipper (bZIP)-
containing transcription factor which is a point of convergence for all three arms 
of UPR; CHOP has binding sites within its promoter for ATF6, ATF4 and XBP1. 
CHOP mediated upregulation of Bim and downregulation of Bcl-2 has been 
reported as the primary mechanism by which CHOP favors pro-apoptotic Bcl-2 
proteins and mediates ER stress induced cell death. CHOP mRNA was 
increased approximately 5-fold (Figure 7A) and CHOP protein was dramatically 










Figure 8. Hepatic activation of JNK, induction of ER stress proteins, and ER 
stress induced apoptotic proteins in mouse livers.   
Western blot analysis of p-JNK, p-eIF2α, GADD/CHOP, and Caspase 12 was 
performed using total cell lysates. Blots were reprobed with antibody to β-actin to 
ensure equivalent loading. Statistical analysis was performed using GraphPad 
Prism Software using one-way ANOVA followed by Bonferroni posttest. **P<0.01. 
Densitometry analysis was performed using Imagelab software. Density ratio was 
calculated using β-actin as control. Numbers represent the mean of density ratio 









The observed alcohol-induced activation of apoptotic signals culminates in 
apoptotic cell death of hepatocyte in the livers of alcohol-fed mice, as seen by an 
increase in TUNEL positive staining in the livers of alcohol-fed mice compared to 
control (Figure 9A, apoptotic cells denoted by arrows). Consistent with elevated 
apoptosis in the liver, alcohol-fed mice exhibited higher liver injury as compared 
to control; liver injury was defined by elevated serum ALT (53.89 ± 9.93 vs. 
7.21 ± 1.05 U/l, p < 0.05), and AST (66.35 ± 25.87 vs. 11.06± 2.18 U/l, p < 0.05) 
activities (Figure 9B). Thus, alcohol-induced accumulation of acrolein and 
consequent ER stress resulted in hepatocyte apoptosis leading to liver injury in 
















Figure 9A. Alcohol consumption results in hepatic apoptosis by terminal 
transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) 
staining assay.  
TUNEL staining of liver sections from Control (C) and alcohol (E) fed mice. 
Arrows indicate TUNEL-positive cells. 
 
 
Figure 9B. Alcohol consumption leads to liver injury (serum ALT and AST).  
Control (C) and alcohol (E). AST and ALT serum levels were measured by 
commercial kits as described in methods. Data are presented as the mean ± SD. 
Statistical analysis was done by t-test. **p<0.01 compared to Control and 





Acrolein mimics the in vivo effects of alcohol in cultured hepatic cells. 
Alcohol consumption and metabolism in the liver is capable of giving rise to many 
toxic metabolites including acetaldehyde, HNE and acrolein. To isolate and 
determine the sole contribution of acrolein in alcohol-induced hepatic injury, we 
used cultured rat hepatic H4IIEC cells to examine the direct in vitro effects of 
acrolein exposure in comparison to alcohol exposure.  These cells are well 
characterized model system for hepatocytes and importantly, are known to 
metabolize alcohol. We first assessed whether in vitro exposure to alcohol 
resulted in the accumulation of acrolein adducts, similar to adducts seen in 
alcohol-fed mouse livers. H4IIEC cells were treated for 24h with relevant 
concentrations of alcohol (200mM) and acrolein (20µM). Considerable acrolein 
adduct accumulation was seen within 6h of alcohol exposure and acrolein adduct 
levels continued to be elevated at 24h compared to untreated cells (Figure 10A). 
Interestingly, the in vitro acrolein adduct accumulation appeared to be greater in 
the cell cytoplasm, rather than the nucleus; whereas in vivo, acrolein adducts 
were equally distributed throughout the cells.  
To further characterize the acrolein-protein adducts, we subjected total protein 
extracts from treated cells to Western blot analysis (Figure 10B). Compared to 
untreated cells, we observed a significant increase in the overall levels of 
acrolein-FDP lysine adducts in the cells treated for 24h with acrolein or alcohol. 
In particular, three proteins with an estimated molecular mass of 46kDa, 56kDa 
and 64kDa were considerably elevated in both alcohol and acrolein exposed 





Figure 10A. Acrolein adduct accumulation in H4IIEC cells (Immunostaining	
with acrolein FDP-lysine antibody). 
Control (C); 200mM Alcohol (E); 20μM Acrolein (A) for 24 hours. Brown color 
indicates presence of acrolein adducts.  
 
 
Figure 10B. Acrolein adduct accumulation in H4IIEC cells (Western Blot). 
H4IIEC cells were treated with varying concentrations of alcohol (50mM, 100mM, 
and 200mM, denoted by E50, E100, and E200) and acrolein (20μM and 30μM, 
denoted by A20 and A30) 24 hours. Western blot analysis was performed using 
total lysates. Blots were reprobed with antibody to β-actin to ensure equivalent 
loading. Densitometry analysis was performed using Imagelab software. Density 
ratio was calculated using β-actin as control. Numbers represent the means of 




Next, we determined the effects of alcohol and elevated acrolein on induction of 
ER stress and consequent apoptotic cell death in hepatocytes. We exposed 
H4IIEC cells to different concentrations of either ethanol (50mM, 100mM or 
200mM) or acrolein (20µM or 30µM). Similar to in vivo alcohol exposure, alcohol 
triggered ER stress and caused increased gene expression of ATF3, ATF4 
mRNA (Figure 11A) and protein (Figure 11B). A parallel result was seen with 
direct treatment of cells with acrolein (Figure 11A and 11B). As seen with in vivo 
alcohol exposure, the adaptive responses to ER stress, namely, upregulation of 
GRP78 and GRP94, were not robust (Figure 11A and 11B). Notably, 
proapoptotic CHOP was significantly upregulated at both mRNA and protein 
levels (Figure 11A and 11B). The up-regulation of proapoptotic signal and CHOP 
expression resulted in apoptotic cell death and decreased cell survival by MTT 
assay (Figure 11C).Thus, our data demonstrate that acrolein mimics the effects 
of alcohol in cultured hepatic cells, suggesting that the adverse effects of alcohol 







Figure 11A. Exposure of H4IIEC cells to alcohol or acrolein causes 
upregulation of ER stress genes by Real time qPCR.  
C=Control; E=alcohol (mM); A=Acrolein (µM). Data are presented as the mean ± 
SD. Statistical analysis was performed using GraphPad Prism Software using 






Figure 11B. ER stress gene expression ATF3, ATF4, GADD/CHOP, GRP78, 
and GRP94 by alcohol (E) or acrolein (A).  
H4IIEC cells were treated with varying concentrations of ethanol (50mM, 100mM, 
and 200mM) and acrolein (20μM and 30μM) 24 hours. Western blot analysis was 
performed using total cell lysates. Blots were probed with ATF3, ATF4, 
GADD/CHOP, GRP78, and GRP94 antibody, then stripped and reprobed with 
antibody to β-actin to ensure equivalent loading. Densitometry analysis was 
performed using Imagelab software. Density ratio was calculated using β-actin as 





Figure 11(C). Cell viability of hepatocytes from alcohol (E) or acrolein (A) 
toxicity.  
Cell viability was measured by MTT assay as described in methods. Alcohol 
200mM (E200) and acrolein 20μM (A20). Data are presented as the mean ± SD. 
Statistical analysis was performed using GraphPad Prism Software using one-












Acrolein scavengers were effective in attenuating the adverse effects of 
both acrolein and alcohol exposure in vitro 
In order to confirm the contribution and establish the pathogenic role of acrolein 
in alcohol-induced ER stress and liver injury, we used known acrolein 
scavengers (N-acetyl cysteine, carnosine and hydralazine) to try to mitigate the 
injurious effects of acrolein build-up in hepatocytes resulting from alcohol and 
acrolein exposure. Acrolein is known to rapidly deplete cellular GSH and cause 
oxidative stress in hepatocytes [1]. Hence, we tested the N-acetylcysteine (NAC), 
a glutathione precursor and antioxidant that was shown to build up intracellular 
GSH and protect against acrolein-induced apoptosis [1, 40]. Carnosine (beta-
alanyl histidine) is an endogenous protein building block that is known to 
scavenge aldehydes, such as acrolein, and to inhibit harmful oxidation and 
glycation reactions [41]. Carnosine is thought to help against aging, autism, 
cataracts, brain and kidney disorders, and diabetic complications. H4IIEC cells 
were pretreated with NAC or carnosine for 45m prior to exposure to alcohol or 
acrolein, and the effects were studied on cell viability. Cell death was monitored 
by the MTT assay. The data show that both NAC and carnosine partially 





Figure 12. Acrolein scavengers protect hepatocytes from alcohol (E) or 
acrolein (A) toxicity.  
Cell viability was measured by MTT assay as described in methods. Control (C); 
20μM Acrolein (A); 200mM Alcohol (E). Data are presented as the mean ± SD 
(n=3). Statistical analysis was performed using GraphPad Prism Software using 











Another acrolein scavenger, hydralazine, which is a vasodilator and 
hypertension drug, is highly selective and effective in preventing acrolein-
mediated oxidative stress and cell death in PC12 cells, and tissue injury in spinal 
cord injury models [42]. Notably, the cytoprotective effects of hydralazine are 
shown to occur not merely by acrolein scavenging but also by effective trapping 
of acrolein-protein adducts [43]. We tested the protective effects of hydralazine 
against acrolein cytotoxicity in vitro (Figure 13A) and against alcohol-induced 










Figure 13. Acrolein scavengers protect from acrolein cytotoxicity in vitro 
(A), and alcohol-induced liver injury in vivo (B).  
(A) Cell viability was measured by MTT assay as described in methods. Control 
(C); 30μM Acrolein (A30). 50μM Hydralazine (HYD). 100μM Carnosine (CAR)  
(B) Serum ALT was measured by commercial activity assay kit. Control (C), 
Alcohol (E), (5mg/kg) body weight Hydralazine (HYD). Statistical analysis was 
done by (A) ANOVA. *p<0.05 compared to Control. (B) ANOVA. ***p<0.001 






In this study, we examined using in vitro (rat hepatic H4IIEC cells) and in vivo 
(C57Bl/6 mice - chronic+binge (NIAAA) alcohol feeding) models how acrolein 
plays a key role on hepatic effects in alcoholic liver disease. We investigated the 
effects of alcohol or acrolein on hepatic ER stress and cell death, and studied 
how acrolein contributed to liver injury in the alcoholic liver disease. Finally, 
acrolein scavengers were tested as potential therapeutic agents in ALD by 
examining their protective effects in the prevention of alcohol-induced ER stress 
and injury cell death.  
Oxidative stress is a salient feature of ALD, and oxidative stress has been 
demonstrated in the absence of ER stress in alcohol fed mice [44]. In the present 
study our experimental results demonstrate elevated protein level of CYP2E1 in 
the livers of alcohol-fed mice following alcohol exposure. Also, the accumulation 
of acrolein adducts were detected in alcohol fed mice liver indicating that alcohol 
consumption results in considerable generation of lipid peroxidation product, 
acrolein,  leading to the buildup of acrolein adducts. These results were also 
supported by in vitro acrolein adducts staining in rat hepatocyte H4IIEC treated 
with alcohol or acrolein which indicated the formation of acrolein adducts from 
alcohol treatment in vitro. Compared to untreated cells, we observed a significant 
increase in the overall levels of acrolein-FDP lysine adducts in the cells treated 
for 24h with acrolein or alcohol. Increased acrolein adducts were detected in vivo 




cytoplasmic adducts is likely to directly trigger ER stress and alter calcium 
homeostasis, and may also lead to the mitochondrial permeability changes that 
are associated with ALD. The nuclear association of acrolein adducted proteins 
is especially interesting and may indicate changes in transcription factors or 
chromatin-modifying proteins such as histone deacetylases and DNA/histone 
methylases, which are likely to have significant effects on gene expression.  
Interestingly, in vitro exposure to either alcohol or acrolein for 24h resulted 
predominantly in cytoplasmic acrolein adducts; the significance of this finding is 
not clear and it is possible that longer exposures may be needed for nuclear 
acrolein buildup. By western blot analysis, we observed an increase in several 
proteins; however, three proteins with an estimated molecular mass of 46kDa, 
56kDa and 64kDa were considerably elevated. The identity of these proteins is 
currently under investigation.  
Our results demonstrate hepatic ER stress and injury in the NIAAA model of 
chronic + binge alcohol consumption. Notably, all three ER stress/UPR pathways 
were stimulated with phosphorylation of PERK, eIF2α, and JNK, proteolytic 
activation of ATF6α, and upregulation of ATF3 and ATF4 mRNA and proteins. 
The mechanisms by which acrolein affects ER stress proteins may be direct via 
adduction of ER stress molecules, or indirect via adduction and alteration of 
function of other proteins that regulate the transcription, translation, stability or 
localization of the ER response proteins. A direct adduction of the ER chaperone 
GRP78 by the lipid aldehyde HNE was shown by Galligan et al, 2014 [45]; 




was seen in the chaperone activity of GRP78 [45]. Notably, among the ER 
chaperone proteins, GRP78 mRNA and protein were upregulated but GRP94 
was only minimally increased (~1.3 fold) at the mRNA level in this in vivo model 
of ALD. Thus, the adaptive responses were not robust and appeared inadequate. 
This is in keeping with the in vitro alcohol and acrolein exposure in H4IIEC cells 
showing modest increase in mRNA but no increases in protein level of GRP78 or 
GRP94; these data are also similar to our published work in HepG2 cells that do 
not express alcohol dehydrogenase or CYP2E1 and are unable to metabolize 
alcohol [1]. The alcohol-induced acrolein accumulation and ER stress were 
associated with significant hepatic steatosis, hepatocyte apoptosis and liver 
injury with a highly significant increase in AST and AST in the alcohol fed mice. 
Thus, these data suggest that alcohol consumption leads to acrolein adducts 
accumulation in the liver, with ER stress and apoptosis, which correlate with liver 
injury.  
Overall, our results suggest that the effects of alcohol on hepatic ER stress and 
hepatocyte cell death and liver injury are mediated, at least in part, by acrolein, 
which is substantially generated with alcohol consumption/metabolism. This 
result is further supported by the in vitro data in H4IIEC cells treated with acrolein 
alone showing that acrolein is able to fully mimic the in vivo effects of alcohol. 
Finally, our data demonstrating that acrolein removal by acrolein scavengers 
protected cells against alcohol induced apoptosis confirmed that acrolein is 
indeed a major mediator of alcohol-induced injury. The mechanisms underlying 




further investigation. Additionally, our data indicate that acrolein clearance may 
be an effective means of curtailing alcohol-induced acrolein-mediated hepatic 




SIGNIFICANCE AND CLINICAL RELEVANCE 
Alcohol consumption causes alcoholic liver disease (ALD) which remains a major 
cause of morbidity and mortality worldwide. Currently, there is no FDA approved 
therapy for ALD. Of the people who drink heavily, only a subset develop clinically 
important ALD and dietary and environmental factors may be critical 
determinants. Dietary polyunsaturated fatty acids (PUFAs), particularly linoleic 
acid, promote alcohol-induced liver damage; linoleic acid consumption has 
dramatically increased and is now a major fat source in the Western diet. Alcohol 
consumption increases lipid peroxidation of PUFAs leading to the generation and 
accumulation of lipid-derived oxidized metabolites, such as acrolein. 
In this study, we investigated the pathological contribution of acrolein in alcohol-
induced liver disease using in vitro (rat hepatic H4IIEC cells) and in vivo (C57Bl/6 
mice - chronic+binge (NIAAA) alcohol feeding) model systems. Our data 
demonstrate that alcohol-induced generation of acrolein in the liver is a major 
pathogenic contributor to hepatic ER stress and liver injury in ALD. Additionally, 
our data indicate that acrolein clearance may be an effective means of curtailing 
alcohol-induced acrolein-mediated hepatic injury, and acrolein scavengers may 
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                                University of Louisville 
2014                        1st Place Student Poster Award, NIEHS Tamburro  
                                Environmental Liver Symposium, Louisville, KY            
Professional Society Memberships 
The American Society for Pharmacology and Experimental Therapeutics  
Society of Toxicology  
Ohio Valley Society of Toxicology  
Abstracts 
2008                       SERMACS 2008 (Southeastern Regional Meeting of the  
                                 American Chemical Society), Nashville, TN  
                                 Essential oils with high Aldehyde Content as inhibitors of  
                                 Human Cytochrome P4502E1 
2011    Research! Louisville 2011 
                                 Louisville, KY 
                                 Induction of the neutrophil chemotactic cytokine - interleukin  
                                 8 (IL-8) by HAART (Highly Active Anti-Retroviral Therapy):  
                                 Relevance to HAART induced hepatotoxicity 
2012    Research! Louisville 2012 
                                 Louisville, KY 
                                 The role of neutrophil chemotactic cytokine - interleukin 8 in 
                                 HAART-induced hepatotoxicity    
2012    OVSOT (Ohio Valley Society of Toxicology) 2012 Annual       
                                 Meeting  
                                 Columbus, OH 
                                 The role of neutrophil chemotactic cytokine - interleukin 8 in 
                                 HAART-induced hepatotoxicity 
2013    Research Society for Alcoholism (RSA) 2013 Annual  
                                 Meeting  
                                 Orlando, FL 
                                 Binge alcohol impairs IFNα antiviral gene expression in mice 
2013    OVSOT (Ohio Valley Society of Toxicology) 2013 Annual       
                                 Meeting, Louisville, KY 
                                 Acrolein, a reactive aldehyde metabolite, is a major mediator 
                                 of alcohol-induced endoplasmic reticulum stress and liver        
                                 injury 
2013    Research! Louisville 2013 
                                 Louisville, KY 
                                 Acrolein, a reactive aldehyde metabolite, is a major mediator  
                                 of alcohol-induced endoplasmic reticulum stress and liver  






2013   AASLD 2013 The Liver meeting 
Washington, D.C. 
Acrolein, a reactive aldehyde metabolite, is a major    
mediator of alcohol-induced endoplasmic reticulum stress   
and liver injury 
2014   Society of Toxicology (SOT) 2014   
Phoenix, AZ  
Acrolein, a Lipid-Derived Aldehyde Metabolite, Is a Critical      
Mediator of Alcohol-Induced Endoplasmic Reticulum Stress   
and Liver Injury  
2014                       American Society for Pharmacology and Experimental   
Therapeutics (ASPET) 2014 
San Diego, CA 
Lipid-derived aldehyde, acrolein, is a critical mediator of                               
alcohol-induced gut-liver injury 
2014   NIEHS Tamburro Environmental Liver Symposium  
Louisville, KY  
Lipid-derived aldehyde, acrolein, is a critical mediator of  
Alcohol- induced gut-liver injury in alcoholic liver disease 
2014   Research! Louisville 2014          
Louisville, KY  
Lipid-derived aldehyde, acrolein, is a critical mediator of   
alcohol-induced gut-liver injury in alcoholic liver disease 
2014   OVSOT (Ohio Valley Society of Toxicology) 2014 Annual     
Meeting 
Dayton, OH 
Lipid-derived aldehyde, acrolein, is a critical mediator of  
alcohol-induced gut-liver injury in alcoholic liver disease 
Lecture presentation 
2014                         Digestive Disease Week (DDW) 2014 
                                 Chicago, IL 
                                 Lipid-derived aldehyde, acrolein, is a critical mediator of   
                                 alcohol-induced gut-liver injury 
2014                         OVSOT (Ohio Valley Society of Toxicology) Summer  
                                 Student Meeting 
                                 Louisville, KY 
                                 Lipid-derived aldehyde, acrolein, is a critical mediator of  
                                 alcohol-induced gut-liver injury 
Publication 
2014                         Lipid-derived aldehyde, acrolein, is a critical mediator of           
                                 alcohol-induced ER stress and liver injury. 
                                 Wei-Yang (Jeremy) Chen, Jingwen Zhang, Craig McClain,  
                                 Shirish Barve, and Swati Joshi-Barve (Manuscript in    
                                 Preparation) 
